Faculty Collaboration Database

Position on reproductive donors and smallpox vaccine: a committee opinion. Fertil Steril 2016 May;105(5):e14-e15

Date

02/02/2016

Pubmed ID

26829211

DOI

10.1016/j.fertnstert.2016.01.027

Scopus ID

2-s2.0-84958231515 (requires institutional sign-in at Scopus site)

Abstract

Although there is presently no definitive evidence linking vaccinia virus transmission through reproductive cells, the Society for Assisted Reproductive Technology (SART) and the American Society for Reproductive Medicine (ASRM) accordingly recommend that assisted reproductive technology (ART) practitioners consider deferring individuals who are planning on donating gametes for reproductive use (reproductive donors) who have recently received smallpox vaccine or contracted symptomatic vaccinia virus infection through close contact with a vaccine recipient (until after the vaccine or infectious scab has spontaneously separated). Good donor practice further suggests that reproductive donors who are not in good health, including those with recent complications from smallpox vaccine, should be similarly deferred. This document replaces the previous document of the same name last published in 2012 (Fertil Steril 2012;98:e1-e2).

Author List

Practice Committees of the American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. Electronic address: ASRM@asrm.org

Author

Jay I. Sandlow MD Chair, Professor in the Urologic Surgery department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Advisory Committees
Female
Humans
Male
Oocyte Donation
Reproductive Medicine
Reproductive Techniques, Assisted
Smallpox
Smallpox Vaccine
Societies, Medical
Tissue Donors